Short-term efficacy and safety of standard interferon with a low accelerating dosage regimen in HCV-related decompensated cirrhosis.
	    		
		   		
		   			
		   		
	    	
    	 
    	10.3760/cma.j.issn.1007-3418.2010.12.018
   		
        
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		Fan-pu JI
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Zheng-xiao LI
			        		
			        		;
		        		
		        		
		        		
			        		Zhi-fang CAI
			        		
			        		;
		        		
		        		
		        		
			        		Chang-yin TIAN
			        		
			        		;
		        		
		        		
		        		
			        		Hong-an XUE
			        		
			        		;
		        		
		        		
		        		
			        		Guo-ying PAN
			        		
			        		;
		        		
		        		
		        		
			        		Hong DENG
			        		
			        		
		        		
		        		
		        		
		        		
		        			
			        		
			        		Author Information
			        		
		        		
		        		
			        		
			        		
			        			1. Department of Infectious Diseases, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China.
			        		
		        		
	        		
        		 
        	
        	
        	
        		- Publication Type:Journal Article
 
        	
        	
            
            	- MeSH:
            	
	        			
	        				
	        				
				        		
					        		Aged;
				        		
			        		
				        		
					        		Female;
				        		
			        		
				        		
					        		Hepatitis C, Chronic;
				        		
			        		
				        		
					        		complications;
				        		
			        		
				        		
					        		Humans;
				        		
			        		
				        		
					        		Interferons;
				        		
			        		
				        		
					        		administration & dosage;
				        		
			        		
				        		
					        		adverse effects;
				        		
			        		
				        		
					        		therapeutic use;
				        		
			        		
				        		
					        		Liver Cirrhosis;
				        		
			        		
				        		
					        		drug therapy;
				        		
			        		
				        		
					        		etiology;
				        		
			        		
				        		
					        		Male;
				        		
			        		
				        		
					        		Middle Aged;
				        		
			        		
				        		
					        		Treatment Outcome
				        		
			        		
	        			
	        			
            	
            	
 
            
            
            	- From:
	            		
	            			Chinese Journal of Hepatology
	            		
	            		 2010;18(12):946-948
	            	
            	
 
            
            
            	- CountryChina
 
            
            
            	- Language:Chinese